Pilot Clinical Trial to Assess the Safety of NMS-01 in Patients With Mild to Moderate Alzheimer's Disease
NCT:NCT07869238 · RECRUITING
廣告
NCT IDNCT07869238
狀態RECRUITING
開始日期2026-01-05
完成時間2026-11-30
SponsorNeumous Inc. (INDUSTRY)
First posted
Last updated
簡要摘要
A single-center, single-arm, prospective, open-label, pilot clinical trial to evaluate the safety and efficacy of the Focused ultrasound stimulator system (NMS-01) for transient Blood-Brain Barrier (BBB) opening in patients with mild to moderate Alzheimer's disease
官方來源
在 ClinicalTrials.gov 上查看 →資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。